BU98008, a Highly Selective Imidazoline1-Receptor Ligand

Annals of the New York Academy of Sciences

Volumn 1009, Issue , 2003, Pages 283-287

  Robinson, E S J ^a   Price, R E ^a   Nutt, D J ^a   Hudson, A L ^a,b  

^a Dept Anat Sch Med Sci U   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

Blood pressure; I1 receptor; Radioligand binding

Indexed keywords

1 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)ISOQUINOLINE; ALPHA 2 ADRENERGIC RECEPTOR; BU 98008; CLONIDINE; IMIDAZOLINE I1 RECEPTOR; ISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING AFFINITY; BLOOD PRESSURE; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ESSENTIAL HYPERTENSION; IC 50; KIDNEY; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 1342347768     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1304.037     Document Type: Conference Paper

References (8)

1. 2-adrenoceptors in ventrolateral medulla. Eur. J. Pharmacol. 134: 1-13.
2. EGLEN, R.M., et al. 1998. "Seeing through a glass darkly": casting light on imidazoline "I" sites. Trends Pharmacol. Sci. 19: 381-390.
3. 3H]Clonidine binding sites in rat kidney: a model for putative central imidazolinel-sites. Br. J. Pharmacol. 125: 76P.
4. MALLARD, N.J., et al. 1992. Characterisation and autoradiographical localisation of non-adrenoceptor idazoxan binding sites in rat brain. Br. J. Pharmacol. 106: 1019-1027.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108.
6. 1 receptor specific agent. J. Med. Chem. 39: 1193-1195.
7. 2-adrenoceptor transgenic mice. Br. J. Pharmacol. 126: 1522-1530.
8. 2-adrenergic receptors are not required for central antihypertensive action of moxonidine in mice. Brain Res. 862: 26-35.